XML 37 R27.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders’ Equity and Equity Incentive Plans (Tables)
 6 Months Ended
Jul. 31, 2024
Stockholders' Equity Note [Abstract]  
Schedule of Stock Option Activity Under Equity Incentive Plan
A summary of stock option activity under our equity incentive plan and related information is as follows:
 Stock Options
Outstanding
Stock
Options		Weighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Life (Years)		Aggregate
Intrinsic
Value
(in thousands, except share, life, and per share data)
Balance as of January 31, 20243,314,228 $8.21 3.9$189,921 
Exercised(221,827)$8.36 $12,034 
Canceled/forfeited/expired(6,188)$92.67 
Outstanding and exercisable as of July 31, 2024
3,086,213 $8.03 3.4$164,855 
Schedule of Restricted Stock Units (RSUs) Activity Under Equity Incentive Plan
A summary of RSU activity under our equity incentive plan and related information is as follows:
RSUs
RSUsWeighted-
Average
Grant Date Fair Value Per Share
Unvested as of January 31, 202426,040,557 $83.14 
Granted8,361,293 $62.62 
Vested(6,778,788)$86.27 
Canceled/forfeited(1,932,193)$81.53 
Unvested as of July 31, 202425,690,869 $75.76 
Schedule of Stock-Based Compensation Expense by Line Item
The stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows:
Three Months Ended July 31, Six Months Ended July 31,
2024202320242023
(in thousands)
Cost of revenue$31,299 $37,535 $62,874 $75,624 
Research and development81,597 82,037 164,166 163,503 
Sales and marketing84,225 93,918 161,459 206,511 
General and administrative40,829 48,019 78,876 98,216 
Total stock-based compensation expense$237,950 $261,509 $467,375 $543,854 
Benefit from income taxes(43,742)(48,766)(87,216)(98,443)
Total stock-based compensation expense recorded to net income$194,208 $212,743 $380,159 $445,411